American Society for Clinical Pathology
Composite Pheochromocytoma: A Clinicopathologic and Molecular Comparison With Ordinary Pheochromocytoma and Neuroblastoma

Jessica M. Comstock, MD
Department of Pathology, University of Utah School of Medicine, Salt Lake City

Carlynn Willmore-Payne MT(ASCP)
Department of Pathology, University of Utah School of Medicine, Salt Lake City

Joseph A. Holden, MD, PhD
Department of Pathology, University of Utah School of Medicine, Salt Lake City

Cheryl M. Coffin, MD
Department of Pathology, University of Utah School of Medicine, Salt Lake City

 

Keywords: Pheochromocytoma; Composite pheochromocytoma; Neuroblastoma; Adrenal tumors

Upon completion of this activity, you will be able to:

  • describe the histologic and clinical features of composite pheochromocytoma.
  • compare the histologic and clinical features of composite pheochromocytoma with those of ordinary pheochromocytoma and neuroblastoma.
  • discuss the role of N-myc testing in composite pheochromocytoma

This activity meets MOC Part II Lifelong Learning requirements. A self-assessment option is available for pathologists attending this program to earn SAM credits for Maintenance of Certification, Part II Self-Assessment Modules (MOC-SAM) for part of the course.

List Price
$20.00
Member Price
$15.00



Member Login


Store Search
From: 
Email:  
To: 
Email:  
Subject: 
Message: